The Binding Site

The Binding Site The Specialist Protein Company

Binding Site, Part of Thermo Fisher Scientific, is committed to improving patient lives worldwide through education, collaboration and innovation. Binding Site provide diagnostic solutions that help doctors, clinicians and laboratory researchers across the globe diagnose and monitor blood cancers and immune system disorders. Founded by researchers at the University of Birmingham, Binding Site has continued to build on its strong scientific foundations, supporting research and development within our field and responding to the changing needs of patients, researchers and clinicians for over 30 years. We are committed to working in collaboration with our partners and customers to lead the way in specialized medical diagnostics, ensuring we continue to make a difference together.

Meet the team behind the science! Our Scientific Team are heading to to share insights, collaborate with clinicians, a...
01/12/2025

Meet the team behind the science!

Our Scientific Team are heading to to share insights, collaborate with clinicians, and support education in plasma cell disorder diagnostics.

Visit us at booth 2171, to learn how our experts are helping bridge science and clinical practice. http://spr.ly/61807xSgm

Only one week to go until in Orlando We’re looking forward to joining the global hematology community to exchange know...
28/11/2025

Only one week to go until in Orlando

We’re looking forward to joining the global hematology community to exchange knowledge, share new insights, and advance education in Multiple Myeloma diagnostics and patient care.

Visit Binding Site, part of Thermo Fisher Scientific at booth 2171 to connect with our team.

Learn more 👉 http://spr.ly/61897UjTR

Early and accurate detection of monoclonal proteins is essential to improving outcomes for patients with plasma cell dis...
27/11/2025

Early and accurate detection of monoclonal proteins is essential to improving outcomes for patients with plasma cell disorders.

Traditional electrophoretic methods have long been the standard — but limitations in sensitivity and subjectivity may lead to uncertainty in diagnosis.

Explore how Binding Site’s latest innovation, the EXENT® System, brings greater diagnostic confidence for clinicians. 👉 http://spr.ly/61887Ujiw

Mass spectrometry offers a new dimension in understanding monoclonal protein biology. By identifying mass-shifted light ...
25/11/2025

Mass spectrometry offers a new dimension in understanding monoclonal protein biology.

By identifying mass-shifted light chains that indicate glycosylated immunoglobulin light chains, laboratories can gain powerful prognostic insights that may not be visible with conventional methods.

This innovation provides clinicians with the confidence to better identify high-risk patients and make informed decisions from diagnosis.

Learn how the EXENT® System is transforming the landscape of plasma cell disorder diagnostics 👉 http://spr.ly/61877oukL

In a few days join us for a webinar on Improving Guideline Adherent Multiple Myeloma Diagnostics with Primary Care Provi...
14/11/2025

In a few days join us for a webinar on Improving Guideline Adherent Multiple Myeloma Diagnostics with Primary Care Provider Perspectives, from Bhrugu Yagnik, MS, PhD, Medical Science Liaison at Binding Site, part of Thermo Fisher Scientific.

📅 Monday 17th November | 15:00 (GMT)
📍 Online Webinar
✅ Register now: http://spr.ly/61847ZbHm

Now available in the Canada! We’re proud to announce that the EXENT® System from Binding Site, part of Thermo Fisher Sci...
12/11/2025

Now available in the Canada! We’re proud to announce that the EXENT® System from Binding Site, part of Thermo Fisher Scientific is now available to support clinical laboratories within the Canada.

The EXENT® System is an automated MALDI-ToF mass spectrometry platform designed to bring greater clarity, accuracy, and efficiency to aid in the diagnosis of multiple myeloma and related disorders. Empowering clinicians with precise, automated results that reduce interpretation variability and more confident diagnoses.

Learn more about the EXENT® System here 👉 http://spr.ly/61817n3q1

Now available in the US! We’re proud to announce that the EXENT® System from Binding Site, part of Thermo Fisher Scienti...
12/11/2025

Now available in the US! We’re proud to announce that the EXENT® System from Binding Site, part of Thermo Fisher Scientific is now available to support clinical laboratories within the Canada.

The EXENT® System is an automated MALDI-ToF mass spectrometry platform designed to bring greater clarity, accuracy, and efficiency to aid in the diagnosis of multiple myeloma and related disorders. Empowering clinicians with precise, automated results that reduce interpretation variability and more confident diagnoses.

Learn more about the EXENT® System here 👉 http://spr.ly/61837nBo7

What key knowledge and practice gaps hinder primary care providers in accurately diagnosing and managing multiple myelom...
10/11/2025

What key knowledge and practice gaps hinder primary care providers in accurately diagnosing and managing multiple myeloma patients?

Join Bhrugu Yagnik, MS, PhD, Medical Science Liaison at Binding Site, part of Thermo Fisher Scientific, on Monday 17th November | 3pm (GMT) / 11am (EST) and will discuss how enhanced collaboration between laboratory and primary care can drive more efficient testing for multiple myeloma.

Register here: https://www.selectscience.net/webinar/enhancing-guideline-adherent-testing-for-multiple-myeloma

We are proud to be attending this year’s American Society of Hematology (ASH) Annual Meeting in Orlando.We look forward ...
06/11/2025

We are proud to be attending this year’s American Society of Hematology (ASH) Annual Meeting in Orlando.

We look forward to connecting with clinicians, researchers, and laboratory professionals to share insights and showcase our industry-leading diagnostic innovations that advance confidence in Multiple Myeloma testing and patient care.

Did you know? Freelite assays were used to establish the free light chain (FLC) values recommended in international guid...
04/11/2025

Did you know? Freelite assays were used to establish the free light chain (FLC) values recommended in international guidelines for the diagnosis and monitoring of monoclonal gammopathies. These recommendations cannot be assumed to apply to FLC assays produced by other manufacturers.

Learn why the choice of FLC test matters 👉 http://spr.ly/6183ACcMh

We’re excited to be attending IPIC2025 in Prague! Join us from 5–7 November. Visit us at booth 24, meet our experts and ...
31/10/2025

We’re excited to be attending IPIC2025 in Prague! Join us from 5–7 November. Visit us at booth 24, meet our experts and discover how we are helping advance immunology diagnostics.

How are you measuring T-cell independent response? Explore our comprehensive range of tests designed to support accurate and reliable immune function assessment. 👉 http://spr.ly/61857G96U

The international guidelines for diagnosing and monitoring monoclonal gammopathies recommend serum free light chain (sFL...
29/10/2025

The international guidelines for diagnosing and monitoring monoclonal gammopathies recommend serum free light chain (sFLC) values established with Freelite assays. These values cannot be assumed to apply to FLC assays produced by other manufacturers.

Learn why assay choice matters for accurate diagnosis and monitoring of monoclonal gammopathies 👉 http://spr.ly/6187ACc8t

Address

8 Calthorpe Road, Edgbaston
Birmingham
B151QT

Opening Hours

Monday 7:30am - 5pm
Tuesday 7:30am - 5pm
Wednesday 7:30am - 5pm
Thursday 7:30am - 5pm
Friday 7:30am - 5pm

Telephone

+441214569500

Website

Alerts

Be the first to know and let us send you an email when The Binding Site posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to The Binding Site:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category